Phenotype measures set:   McMullan6   lean_end

ID, description, units MPD:61536   lean_end   percentage of body mass that is lean after 4 wks of treatment   [%]
exercise study
Measures • no exercise group    • moderate intensity group    • high intensity group
Data set, strains McMullan6   CC   4 strains     sex: both     age: 8-10wks
Procedure MRI
Comparisoncontrol group vs. multiple treatment / dosage groups
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

McMullan6 - percentage of body mass that is lean after 4 wks of treatment





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
group 2 111.8771 55.9386 6.2294 0.0023
sex 1 192.2838 192.2838 21.413 < 0.0001
strain 3 1479.7312 493.2437 54.9284 < 0.0001
group:sex 2 90.1246 45.0623 5.0182 0.0074
group:strain 6 230.0896 38.3483 4.2705 0.0004
sex:strain 3 140.6962 46.8987 5.2227 0.0017
group:sex:strain 6 101.1057 16.851 1.8765 0.0861
Residuals 214 1921.6684 8.9798

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelStrains
tested
SexAge
McMullan6 61536 MRI exercise percentage of body mass that is lean after 4 wks of treatment   [%]   no exercise group   lean_end_ctrl CC 4 both 8-10wks
McMullan6 61537 MRI exercise percentage of body mass that is lean after 4 wks of treatment   [%]   moderate intensity group   lean_end_MICT CC 4 both 8-10wks
McMullan6 61538 MRI exercise percentage of body mass that is lean after 4 wks of treatment   [%]   high intensity group   lean_end_HIIT CC 4 both 8-10wks